Paid-members only Markets Featured Top 10 Stocks We're Watching This Week — Summit Week Edition Refineries burning on two continents while crude falls 9 percent, the Xi-Trump summit Thursday, Micron's positioning week, and the SEC's tokenization runway. Ten fresh names for the week ahead, all tracked on the Watchlist from these prices.
Paid-members only Geopolitics Featured The Oil Market Just Lost Its Plan B. It's Acting Like Nothing Happened. Drones shut Saudi Arabia's Hormuz bypass just as tankers came under fire in the strait itself. Both exits from the Gulf are now contested — and $105 Brent is pricing the repair, not the precedent.
Paid-members only Energy Featured Copper's Record Lasted Five Days. The Shortage Didn't. LME copper hit an all-time high of $14,875 a ton on September 10, then fell 6% in five days — on a Washington headline, not a single ton of new supply. The curve flipped to contango while the deficit forecasts never moved. Which signal do you trust with your money?
Space Economy Featured Europe Finally Has Rockets A private German rocket just reached orbit from European soil for the first time in history. Behind it: a €900 million ESA contest run on the NASA playbook, a £7.8 billion UK strategy, and the end of Europe's 50-year launch monopoly.
Paid-members only Energy Featured Is the Copper Squeeze Over? The Smelters Say No. Copper fell 6% from its record and the futures curve flipped to contango — but the benchmark fee for smelting copper just reset to zero. What the concentrate market knows that the warehouse data doesn't.
Paid-members only Finance Featured The First Drug That Edits Your DNA Is Finally Selling Casgevy revenue grew 78% in a single quarter and the FDA just opened the label to two-year-olds. The first CRISPR medicine is finally a business — and the market is still pricing its maker like a science project.
Paid-members only Markets Featured The Quantum Trade Isn't About Quantum Computers On Monday, Washington retires the certification standard behind thousands of encryption products — the first hard deadline in a forced, decade-long rebuild of the internet's cryptographic plumbing. The money gets spent whether Q-Day ever arrives or not.
Macro Featured The First Rate Hike of the War Economy The Fed just raised rates for the first time since 2023 — days after the second-worst consumer sentiment reading on record. What a tightening cycle in a war economy means for inflation, mortgages, and markets.
Members only Macro Featured The Reshoring Boom Is Real. The Jobs Aren't. America has announced $1.6 trillion in new factories while manufacturing employment falls and Asian imports hit a four-year high. Both datasets are right — and the gap between them is a three-phase trade most investors are pricing as one.
Finance Featured Sports Just Had a $30 Billion Summer. The Sellers Know Something. The Lakers sold twice in 14 months, the Seahawks and Angels set league records, and $30 billion in franchises changed hands in one summer. Why America's founding sports families are all selling at once — and what it signals for the asset class.
Members only Markets Featured America's First Transcontinental Railroad Is on Trial Union Pacific's $85 billion bid for Norfolk Southern just entered its merits phase at the STB — with every rival railroad, two unions, and half the shipping industry against it. The 16% merger spread says the market is pricing a coin flip.
Paid-members only Finance Featured Crypto's Big Bill Just Died 10 Votes Short. The Next Vote Is the Midterms. The friendliest Congress crypto will ever get just killed its market-structure bill 50-49. Who regulates digital assets for the next 15 months, and why Circle and Coinbase are opposite trades.
Macro Featured Half of America's Hospitals No Longer Deliver Babies Over 700 maternity wards have closed since 2010, one in three US counties is now a maternity care desert — and the Medicaid cuts arriving in January will accelerate the exit. The economics behind a quiet structural crisis.
Members only Markets Featured Indonesia Keeps Firing Its Finance Ministers Prabowo just installed his third finance minister in under two years. Markets cheered the name — but the pattern is the story, and it decides how to price everything from the rupiah to the Jakarta bond curve.
Paid-members only Defence Featured The Pentagon Just Outsourced Its Missile Shortage to Germany A new US-Germany pact turns Bavaria into an overflow factory for America's scarcest munitions — Patriot interceptors now, Tomahawk components next. The deal says more about empty American magazines than alliance politics, and it redraws who profits from European rearmament.
Infrastructure Featured Washington Promised 500,000 EV Chargers. The Market Built the Network Instead. The $5 billion federal charging program produced a few hundred ports in five years and just lost half a billion in funding. Private networks are switching on 1,000+ fast-charging stalls a month — and the winners are already visible.
Markets Featured Europe Just Put the Global Software Industry on a 24-Hour Clock The EU's Cyber Resilience Act just started a 24-hour vulnerability reporting clock for every software maker selling in Europe — as AI collapses exploit timelines from weeks to seconds. Who pays, and who profits.
Paid-members only Macro Featured The Most Important Rate Decision This Week Isn't the Fed's Japan's 10-year yield just broke 3% for the first time since 1996, the 30-year hit a record, and the BOJ decides Friday — one day after the Fed. The end of the world's cheapest money is the macro story markets haven't priced.
Paid-members only Energy Featured The Uranium Price Everyone Watches Is the Wrong One Uranium's long-term contract price just broke a record that stood since 2007 — while spot idles in the high $80s and the miners sit out the move. The gap between the two prices is the most important signal in the energy market right now.
Paid-members only Markets Featured The Best-Selling Drug in History Just Lost a Head-to-Head Trial A Chinese-invented drug just beat Merck's Keytruda on overall survival — a first. What it means for pharma's biggest franchise, the PD-1/VEGF gold rush, and Summit Therapeutics' $14 billion valuation.
Paid-members only Markets Featured A Jury Called Live Nation a Monopoly. The Stock Refuses to Believe It. Five months after a jury found Live Nation and Ticketmaster liable for illegal monopolization on every claim, LYV trades at $170 as if nothing happened. The market is making one very specific bet about remedies — here is the case for and against it.
Paid-members only Artificial Intelligence Featured Dario, Sam, and Elon Just Asked to Slow AI Down. Beijing Called It a Cold War Play. The Money Kept Racing. The three CEOs running the AI race called for a slowdown in the same news cycle. Trump said no, China called it containment, and Anthropic picked Nasdaq for its IPO the same weekend. All five theories of what is really happening, and the stocks that win across the branches.
Infrastructure Featured You Can Meet Them at the Gate Again Twenty-five years after 9/11, Washington is quietly dismantling the airport security state: shoes stay on, liquids rules are dying lane by lane, and non-travelers can reach the gate again. The rollback is a technology story — and an investable one.
Geopolitics The Strait of Hormuz, Explained for Investors One in five barrels of oil on Earth passes through a 21-mile-wide waterway between Iran and Oman. The complete investor's guide to the world's most important chokepoint: how it works, what history shows, and how the risk reaches your portfolio.
Paid-members only Markets Featured Top 10 Stocks We're Watching — Fed Week Edition The watchlist is back for the most loaded week of the year: a Fed priced at ~90% to hike, $100 oil, record tanker rates, and gold at $4,400. Ten names split between short-term catalyst trades and long-term positions the macro is validating.
